Skip to content

Clinical trials

Phase 3 Lung Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 3 Clear all

311 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200012
200115
200210
20036
20047
200511
200614
200711
200811
200911
20106
20114
20124
201311
20149
20157
201612
20177
201810
20198
202014
20218
20226
202310
202414
202518
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed149
Terminated45
Unknown status43
Recruiting35
Active, not recruiting24
Not yet recruiting7
Withdrawn7
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology19
National Cancer Institute (NCI)12
AstraZeneca9
European Organisation for Research and Treatment of Cancer - EORTC7
Radiation Therapy Oncology Group7
Bristol-Myers Squibb6
Merck Sharp & Dohme LLC6
NCIC Clinical Trials Group5
NRG Oncology5
SWOG Cancer Research Network5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms311
Carcinoma, Non-Small-Cell Lung167
Adenocarcinoma of Lung23
Small Cell Lung Carcinoma22
Neoplasms20
Breast Neoplasms14
Neoplasm Metastasis12
Lung Diseases11
Thoracic Neoplasms10
Adenocarcinoma, Bronchiolo-Alveolar9

Trials

Showing 51 to 75 of 311. Each trial links to its page on Pharma Observatory.

211 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.